Characterization of water-soluble esters of nitrobenzoxadiazole-based GSTP1-1 inhibitors for cancer treatment.


Journal

Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032

Informations de publication

Date de publication:
08 2020
Historique:
received: 27 03 2020
accepted: 25 05 2020
pubmed: 1 6 2020
medline: 15 12 2020
entrez: 1 6 2020
Statut: ppublish

Résumé

The 7-nitrobenzo[c][1,2,5]oxadiazole (NBD) derivative NBDHEX (compound 1) and its analogue MC3181 (compound 2) have been found to be potent inhibitors of tumor cell growth in vitro and therapeutically active and safe in mice bearing human melanoma xenografts. To enhance the aqueous solubility of these compounds, we synthesized the hemisuccinate of 1 (compound 3) and the phosphate monoesters of 1 and 2 (compound 4 and 5, respectively). These novel NBD derivatives displayed a solubility in the conventional phosphate-buffered saline up to 150-fold higher than that of 1, and up to 4-fold higher than that of 2. Notably, solubility of phosphates 4 and 5 in a potassium phosphate buffer at pH 7.4, was up to 500-fold higher than that of 1, and ~10-fold higher than that of 2. Compounds 3-5 retained high cytotoxicity towards cultured human melanoma and osteosarcoma cells and were cleaved in vitro by both human and murine hydrolases, thus releasing the corresponding parent compound (i.e., 1 or 2). Interestingly, esters 3-5 displayed high inhibitory activity towards the glutathione transferase (GST) isoform GSTP1-1 and showed a reactivity towards reduced glutathione comparable to that of the respective parent compound. Finally, both 4 and 5 were safe and effective when administered intravenously or orally as an aqueous solution to mice xenografted with A375 human melanoma tumors. Collectively, these results and the previously observed synergistic interaction between 1 and 2 and various approved anticancer drugs, suggest the possible utility of phosphates 4 and 5 as single agents and in combination regimens in cancers with unmet medical need, including melanoma.

Identifiants

pubmed: 32473836
pii: S0006-2952(20)30294-X
doi: 10.1016/j.bcp.2020.114060
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Esters 0
Water 059QF0KO0R
GSTP1 protein, human EC 2.5.1.18
Glutathione S-Transferase pi EC 2.5.1.18
Glutathione Transferase EC 2.5.1.18
glutathione S-transferase Mu 2 EC 2.5.1.18
4-Chloro-7-nitrobenzofurazan EQF2794IRE

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114060

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Veronica Di Paolo (V)

Laboratory of Drug Metabolism, Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.

Chiara Fulci (C)

Department of Chemical Sciences and Technologies, University of Rome "Tor Vergata", Rome, Italy.

Dante Rotili (D)

Department of Chemistry and Technologies of Drugs, University of Rome "Sapienza", Rome, Italy. Electronic address: dante.rotili@uniroma1.it.

Anastasia De Luca (A)

Department of Biology, University of Rome "Tor Vergata", Rome, Italy.

Stefano Tomassi (S)

Department of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy.

Massimo Serra (M)

IRCCS Istituto Ortopedico Rizzoli, Pharmacogenomics and Pharmacogenetics Research Unit, Laboratory of Experimental Oncology, Bologna, Italy.

Manuel Scimeca (M)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.

Cristina Geroni (C)

Department of Chemical Sciences and Technologies, University of Rome "Tor Vergata", Rome, Italy.

Luigi Quintieri (L)

Laboratory of Drug Metabolism, Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy. Electronic address: luigi.quintieri@unipd.it.

Anna Maria Caccuri (AM)

Department of Chemical Sciences and Technologies, University of Rome "Tor Vergata", Rome, Italy; The NAST Centre for Nanoscience and Nanotechnology and Innovative Instrumentation, University of Rome "Tor Vergata", Rome, Italy. Electronic address: caccuri@uniroma2.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH